Fresh analysis reveals that individuals who stop using popular weight-loss injections like Mounjaro or Wegovy can put back on lost weight at a significantly accelerated pace than those who stop conventional diet and exercise regimens.
Published data in a leading health publication shows that while obese people often shed substantial amounts of their body weight while on the medication, the weight comes back at an average rate of 0.8 kg per month after stopping.
"Users purchasing such treatments should be aware of the danger of fast weight regain when the medication concludes," cautioned expert Dr. Susan Jebb.
This pace of regain means a reversion to pre-treatment mass within about a year and a half.
Comparing Therapies
The research, which examined dozens of studies involving thousands of participants, compared the outcomes of these new drugs with older methods.
Researchers point out that people who shed pounds through lifestyle changes alone generally have a slower creep back—approximately 100 grams monthly—once they finish.
Explaining the Rapid Regain
Nutrition scientists suggest the mechanism of the jabs explains the amplified regain.
The injections mimic a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.
"Long-term administration of GLP-1 levels far above than normal may cause the system to produce less of its endogenous hormone, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication means hunger is no longer kept in check, making excessive eating far more likely."
A Lifelong Issue?
Medical guidelines suggest the jabs for people with obesity-related health risks, alongside prescribed diet and exercise modifications.
Professionals argue that, given the likelihood of weight regain, the therapy is often long-term.
This view is reinforced by pharmaceutical companies, who note that the results "highlight the long-term nature of obesity," similar to managing conditions like high blood pressure.
User Testimonies
People who have come off the medication describe a powerful return of hunger.
"It felt as if something flipping and I was suddenly starving," said a patient.
This difficulty is exacerbated if users have not established lasting dietary or behavioural modifications during therapy.
Growing Adoption
Survey data indicate that millions of adults in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Adoption is more common among women compared to males.
- The middle-aged demographic shows the greatest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
Ultimately, clinicians emphasize that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic solution and long-term success relies on ongoing lifestyle changes.
